Cartagena Protocol definition

Cartagena Protocol means the Cartagena Protocol on Biodiversity to the Convention adopted at Montreal in January 2000 and any subsequent amendments thereto;
Sample 1Sample 2Sample 3
Cartagena Protocol means the Cartagena Protocol on Biosafety to the Convention on Biological Diversity adopted at Montreal in January 2000;
Sample 1Sample 2Sample 3
Cartagena Protocol means the Cartagena Protocol on Biosafety to the Convention on Biodiversity that entered into force on September 11, 2003.
Sample 1Sample 2

Examples of Cartagena Protocol in a sentence

  • Work Plan of the Intergovernmental Committee for the Cartagena Protocol on Biosafety272.

  • Korea ratified the Cartagena Protocol on Biosafety (CPB) on October 2, 2007.

  • Cartagena Protocol on Biosafety to the Convention on Biological Diversity.

  • The Recipient shall carry out Parts 1.1, 1.3, 1.4, 2, 3.1(b), 3.2, 3.3 and 4(ii) of the Project pursuant to its obligations under, and in accordance with environmental safeguards and international good practice and standards consistent with those of, the Cartagena Protocol on Biosafety.

  • The Cartagena Protocol on Biosafety has developed a framework for the safe use of living genetically modified organisms that may have a harmful effect on biodiversity and human health and entail trans-boundary risks.

  • The point of contact for the Cartagena Protocol in Guatemala is the Technical Office for Biodiversity (OTECBIO), which is part of the Council of Protected Areas (CONAP).

  • The objective of this Action Plan is to facilitate and support the development and strengthening of capacities for the ratification and effective implementation of the Cartagena Protocol on Biosafety at the national, sub regional, regional and global levels in a timely manner.

  • Those reports shall state, both for third countries and Member States that are a significant source of raw material for biofuel consumed within the Community, whether the country has ratified and implemented: – the Cartagena Protocol on Biosafety, – the Convention on International Trade in Endangered Species of Wild Fauna and Flora.

  • Kenya was the first country to sign the Cartagena Protocol on Biosafety (CPB) on January 29, 2000.

  • The Honduras Congress ratified the Cartagena Protocol on Biosafety to the United Nations’ Convention on Biological Diversity in September 2008.


More Definitions of Cartagena Protocol

Cartagena Protocol means the Cartagena Protocol on Biosafety to the Convention on Biological Diversity, adopted in Montreal, Canada, by the Conference of the Parties to the Convention on January 29, 2000.
Sample 1Sample 2
Cartagena Protocol means the Cartagena Protocol on Biosafety to the Convention on Biological Diversity;
Sample 1Sample 2
Cartagena Protocol means the Protocol on Biosafety under the Convention on Biological Diversity;
Sample 1Sample 2
Cartagena Protocol means Cartagena Protocol on Biosafety to the Biodiversity Convention, done at Montreal on 29 January 2000 and ratified by the Parliament of Georgia under its Resolution “On the Accession of Georgia to the Cartagena Protocol to the Convention of Biological Diversity” of 26 September 2008;
Sample 1
Cartagena Protocol means the Cartagena Protocol on Biosafety and set out as the First Schedule;
Sample 1
Cartagena Protocol means the Cartagena Protocol on Biosafety of the United
Sample 1

Related to Cartagena Protocol

  • Kyoto Protocol means the protocol to the UNFCCC adopted at the Third Conference of the Parties to the UNFCCC in Kyoto, Japan on 11 December 1997 as may be amended;

  • Protocol means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;

  • MFDA means the Mutual Fund Dealers Association of Canada;

  • cGMP means current Good Manufacturing Practices as specified in the United States Code of Federal Regulations, ICH Guideline Q7A, or equivalent laws, rules, or regulations of an applicable Regulatory Authority at the time of manufacture.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Collaborative pharmacy practice means a practice of pharmacy whereby one or more pharmacists have jointly agreed, on a voluntary basis, to work in conjunction with one or more practitioners under protocol whereby the pharmacist may perform certain pharmaceutical care functions authorized by the practitioner or practitioners under certain specified conditions or limitations.

  • Licensed clinical social worker means an individual who meets the licensed clinical social worker requirements established in KRS 335.100.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • GMP means the amount proposed by Contractor and accepted by Owner as the maximum cost to Owner for construction of the Project in accordance with this Agreement. The GMP includes Contractor’s Construction Phase Fee, the General Conditions Cost, the Cost of the Work, and Contractor’s Contingency amount.

  • Protocols means written directions and orders, consistent with the department’s standard of care, that are to be followed by an emergency medical care provider in emergency and nonemergency situations. Protocols must be approved by the service program’s medical director and address the care of both adult and pediatric patients.

  • Collaborative pharmacy practice agreement means a written and signed

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Manufacturing Process means any process for—

  • technical specification means a document that prescribes technical requirements to be fulfilled by a product, process or service;

  • Technical Specifications A specification in a document defining the characteristics of a product or a service, such as the quality levels, the environmental and climate performance levels, the design for all needs, including accessibility for people with disabilities, and the evaluation of conformity, of product performance, of the use of the product, safety or dimensions, as well as requirements applicable to the product as regards the name by which it is sold, terminology, symbols, testing and test methods, packaging, marking or labelling, instructions for use, the production processes and methods at every stage in the life cycle of the supply or service, as well as the evaluation and conformity procedures;

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • API means the American Petroleum Institute.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Clean coal technology demonstration project means a project using funds appropriated under the heading “Department of Energy—Clean Coal Technology,” up to a total amount of $2,500,000,000 for commercial demonstration of clean coal technology, or similar projects funded through appropriations for the Environmental Protection Agency. The federal contribution for a qualifying project shall be at least 20 percent of the total cost of the demonstration project.

  • Supply Licence means the licence granted to us under section 6(1)(d) of the Act;